Identification of an intronic single nucleotide polymorphism leading to allele dropout during validation of a CDH1 sequencing assay: Implications for designing polymerase chain reaction-based assays

Genetics in Medicine

Volumn 9, Issue 11, 2007, Pages 752-760

  Mullins, Franklin M ^a   Dietz, Lisa ^a   Lay, Marla ^a   Zehnder, James L ^a   Ford, James ^b   Chun, Nicolette ^b   Schrijver, Iris ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Allele dropout; CDH1; Gastric cancer; HDGC; SNP

Indexed keywords

UVOMORULIN;

ALLELE; ARTICLE; CONTROLLED STUDY; FRAMESHIFT MUTATION; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC IDENTIFICATION; GENETIC SCREENING; HUMAN; HUMAN TISSUE; INTRON; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER;

EID: 36249011430     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/GIM.0b013e318159a369     Document Type: Article

References (17)

1. Guilford P, Hopkins J, Harraway J, McLeod M, et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998;392:402-405.
2. Brooks-Wilson AR, Kaurah P, Suriano G, Leach S, et al. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet 2004;41:508-517.
3. Suriano G, Yew S, Ferreira P, Senz J, et al. Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management. Clin Cancer Res 2005;11:5401-5409.
4. Huntsman DG, Carneiro F, Lewis FR, MacLeod PM, et al. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Engl J Med 2001;344:1904-1909.
5. Ford JM. Inherited susceptibility to gastric cancer: advances in genetics and guidelines for clinical management. Alexandria, VA: ASCO Educational Sessions; 2002:116-125.
6. Norton JA, Ham CM, Dam JV, Jeffrey RB, et al. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer. Ann Surg 2007;245:873-879.
7. Suriano G, Seixas S, Rocha J, Seruca R. A model to infer the pathogenic significance of CDH1 germline missense variants. J Mol Med 2006;84:1023-1031.
8. Ng PC, Henikoff S. Predicting the effects of amino Acid substitutions on protein function. Annu Rev Genomics Hum Genet 2006;7:61-80.
9. Newton CR, Graham A, Heptinstall LE, Powell SJ, et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res 1989;17:2503-2516.
10. Tester DJ, Cronk LB, Carr JL, Schulz V, et al. Allelic dropout in long QT syndrome genetic testing: a possible mechanism underlying false-negative results. Heart Rhythm 2006;3:815-821.
11. Berx G, Cleton-Jansen AM, Nollet F, de Leeuw WJ, et al. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 1995;14:6107-6115.
12. Don RH, Cox PT, Wainwright BJ, Baker K, et al. 'Touchdown' PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res 1991;19:4008.
13. Miller RD, Phillips MS, Jo I, Donaldson MA, et al. High-density single-nucleotide polymorphism maps of the human genome. Genomics 2005;86:117-126.
14. Koboldt DC, Miller RD, Kwok PY. Distribution of human SNPs and its effect on high-throughput genotyping. Hum Mutat 2006;27:249-254.
15. Kaurah P, MacMillan A, Boyd N, Senz J, et al. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA 2007;297:2360-2372.
16. Humar B, Toro T, Graziano F, Muller H, et al. Novel germline CDH1 mutations in hereditary diffuse gastric cancer families. Hum Mutat 2002;19:518-525.
17. More H, Humar B, Weber W, Ward R, et al. Identification of seven novel germline mutations in the human E-cadherin (CDH1) gene. Hum Mutat 2007;28:203.